Podcast


Presenter: Adrienne J Lindblad BSP ACPR PharmD James McCormack BSc (Pharm) Pharm D Mike Allan MD

Podcast: BS Medicine Episode #439 A Hard Look at the Evidence, PDE5 inhibitors in Erectile Dysfunction
0:00

In episode 439, Mike and James invite Adrienne to take us through the impressively large amount of evidence for the PDE5 inhibitors for erectile dysfunction. We find that the NNTs are 2-3 for the not clearly defined endpoint of successful intercourse. There is a 20% absolute increase in adverse effects but almost no one stops…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

CFP Podcast: Navigating the landscape of health data, health informatics and digital health: a conversation with Dr Rashaad Bhyat

In this episode of the CFP Podcast, join Deputy Editor Dr Sarah Fraser and Editor Dr Nick Pimlott in a wide-ranging discussion about health data, health informatics and digital health with Dr…
Listen 0.5 credits available

BS Medicine Episode #581: Antibiotics or no antibiotics for acute diverticulitis, that is the question!

In episode 581, Mike and James invite Mike Kolber back to the podcast for the umpteenth time – this time we talk about a topic we haven’t discussed before –…
Listen 0.5 credits available

BS Medicine Episode #580: (A)dressing the Christmas Tree? Therapies for pityriasis rosea

In episode 580, Mike and James invite Jennifer Young to talk about the treatment of pityriasis rosea. Believe it or not there are 2 simple treatments that seem to work…
Listen 0.5 credits available

Presenter(s):

Adrienne J Lindblad BSP ACPR PharmD James McCormack BSc (Pharm) Pharm D Mike Allan MD

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Adrienne J Lindblad BSP ACPR PharmD
  • James McCormack BSc (Pharm) Pharm D
  • Mike Allan MD

Spearkers do not have any conflicts of interest to declare.